WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 452
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 572

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 8'085  7'920  7'756  7'593  7'431  5'572  4'313  3'304 
Births 223  221  220  218  216  189  150  131 
Surviving infants 213  211  209  207  205  179  141  121 
Pop. less than 5 years 1'033  1'025  1'017  1'011  1'004  845  665  561 
Pop. less than 15 years 2'933  2'900  2'868  2'836  2'802  2'214  1'812  1'441 
Female 15-49 years 2'015  1'968  1'921  1'873  1'827  1'363  1'013  750 

Number of reported cases

(Click for retrospective incidence data for Papua New Guinea)
Diphtheria
ChartChart
  15 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  38  2'299  12  7'135  4'575  12'125 
Mumps
ChartChart
 
Pertussis
ChartChart
  3'188  6'472  2'280  2'084  2'693 
Polio*
ChartChart
  22 
Rubella
ChartChart
  84  33 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  27  32  138 
Tetanus (total)**
ChartChart
  27  32  138  115  68 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Papua New Guinea)
Vaccine year result method % card seen                                                
BCG 2005  90  DHS   70  72  65  81  88  84  81  92  62 
DTP1 2005  88  DHS   70  87  83  87  88  85  84  97 
DTP3 2005  67  DHS   70  61  62  62  68  63  59  68  32 
DTP4         
IPV1          14 
HepB_BD          35  32  31  37  35  24 
HepB3 2005  65  DHS   70  61  62  62  68  63  57  20 
Hib3          61  62  62  68  63 
JapEnc         
MCV1          51  60  65  70  67  62  66 
MCV2          53 
MenA         
PCV1          34  24 
PCV2          25  14 
PCV3          20  20 
Pol3 2005  68  DHS   70  62  63  53  69  70  47  68  29 
Rota1         
RotaC         
RCV1          51 
TT2plus          48  50  50  67  59  10  81  50 
PAB          80 
VAD1          51  69  57  52  18 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Papua New Guinea)
BCG
ChartChart
  89  82  98  99  99  88  92  62 
DTP1
ChartChart
  87  83  87  88  85  84  97  57 
DTP3
ChartChart
  72  73  73  79  74  59  68  32 
HepB3
ChartChart
  66  67  67  73  68  57  20 
HepB_BD
ChartChart
  35  32  31  37  35 
Hib3
ChartChart
  72  73  73  79  74 
IPV1
  14 
MCV1
ChartChart
  70  79  84  89  86  69  67 
MCV2
ChartChart
 
PCV3
ChartChart
  20  20 
Pol3
ChartChart
  73  74  64  80  81  51  68  29 
RCV1
ChartChart
  70  79 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 89  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
79 
   
/
|
|
\
Greater or equal to 90% 9
From 80 to 89% 8
From 50 to 79% 39
Less than 50% 44
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 1, 2, 3 months; Yes
HepB_Pediatric birth; Yes
IPV 3 months; Yes
MR 6, 9, 18 months; Yes
OPV 1, 2, 3 months; Yes
Pneumo_conj 1, 2, 3 months; Yes
TT 7, 13 years; Yes
VitaminA 6, 9, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2011-2015  2011-2015  2011-2015  2011-2015  2011-2015  2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 89  89  89  89  89  89  80 

System performance

Total Nº districts in country number 89  89  89  89  89  89  89 
Nº districts with DTP3 coverage >=80% number 15  18  18  28  35  30  20 
% of districts with DTP3 coverage >=80% From 0 to 100% 17  20  20  31  39  34  22 
Nº districts with measles (MCV1) coverage >=95% number 13  12  23  27  19 
% of districts with MCV1 coverage >=95% From 0 to 100% 15  13  26  30  21 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  Yes  Yes  No  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 34  12  54  25  40  80  75 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.